Bipin N Savani Selected Research

Granulocyte Colony-Stimulating Factor (G-CSF)

1/2020	Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.
1/2020	The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation.
8/2017	Sources of Hematopoietic Stem and Progenitor Cells and Methods to Optimize Yields for Clinical Cell Therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bipin N Savani Research Topics

Disease

57	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 03/2009
55	Leukemia 01/2022 - 02/2006
44	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 08/2005
35	Neoplasms (Cancer) 01/2022 - 09/2005
20	Hematologic Neoplasms (Hematological Malignancy) 01/2022 - 03/2005
19	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 09/2007
15	Bronchiolitis Obliterans Syndrome 01/2022 - 12/2006
14	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 11/2021 - 08/2005
13	Multiple Myeloma 01/2022 - 12/2012
13	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2020 - 02/2006
12	Lymphoma (Lymphomas) 01/2022 - 09/2011
8	Pathologic Complete Response 01/2022 - 02/2012
7	Hematologic Diseases (Blood Diseases) 01/2021 - 12/2006
7	Infections 01/2021 - 03/2005
7	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2020 - 05/2013
6	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2019 - 12/2012
5	Hodgkin Disease (Hodgkin's Disease) 01/2019 - 06/2015
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 04/2009
4	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 12/2019
4	Residual Neoplasm 01/2020 - 01/2008
4	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2018 - 05/2013
3	Infertility (Sterility) 01/2022 - 08/2017
3	Hemorrhage 01/2022 - 03/2006
3	Obesity 01/2022 - 06/2011
3	COVID-19 03/2021 - 04/2020
3	Sickle Cell Anemia (Hemoglobin S Disease) 01/2021 - 11/2017
3	Aplastic Anemia (Anemia, Hypoplastic) 01/2021 - 02/2011
3	Chromosome Aberrations (Chromosome Abnormalities) 01/2021 - 01/2018
3	Primary Myelofibrosis (Myelosclerosis) 12/2020 - 01/2014
3	Dyslipidemias (Dyslipidemia) 10/2018 - 08/2010
3	Diabetes Mellitus 03/2017 - 01/2011
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2016 - 08/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2016 - 06/2011
3	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 10/2015 - 05/2012
2	Hypogonadism (Hypergonadotropic Hypogonadism) 01/2022 - 01/2022
2	Blast Crisis (Blast Phase) 10/2020 - 10/2005
2	Necrosis 10/2020 - 04/2014
2	Body Weight (Weight, Body) 01/2020 - 01/2020
2	Rare Diseases (Rare Disease) 01/2020 - 11/2015
2	monosomy Chromosome 7 01/2020 - 01/2018
2	Overweight 01/2020 - 01/2015
2	Autoimmune Diseases (Autoimmune Disease) 01/2019 - 07/2011
2	Multiple Sclerosis 01/2019 - 10/2013
2	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2019 - 07/2012
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 11/2017 - 10/2015
2	Hypothyroidism 08/2017 - 03/2009
2	Splenomegaly 02/2015 - 09/2012

Drug/Important Bio-Agent (IBA)

22	Cyclophosphamide (Cytoxan)FDA LinkGeneric 11/2022 - 03/2005
16	fludarabineIBA 01/2022 - 08/2005
15	Busulfan (Busulfex)FDA Link 01/2022 - 08/2005
9	AntigensIBA 01/2022 - 09/2005
9	Chimeric Antigen ReceptorsIBA 01/2022 - 01/2019
6	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2009
6	Rituximab (Mabthera)FDA Link 01/2020 - 06/2012
6	Calcineurin InhibitorsIBA 01/2019 - 03/2016
5	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2020 - 01/2017
5	Peptides (Polypeptides)IBA 07/2012 - 07/2007
4	Thiotepa (Triethylenethiophosphoramide)FDA LinkGeneric 01/2022 - 01/2018
4	Melphalan (Alkeran)FDA LinkGeneric 01/2022 - 08/2005
4	tisagenlecleucelIBA 12/2019 - 01/2019
4	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2019 - 03/2016
4	Bortezomib (Velcade)FDA Link 12/2018 - 01/2009
3	treosulfanIBA 01/2022 - 07/2017
3	SteroidsIBA 11/2021 - 07/2013
3	Alemtuzumab (Campath)FDA Link 01/2020 - 04/2009
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 12/2012
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2020 - 08/2017
3	Pharmaceutical PreparationsIBA 12/2019 - 01/2019
3	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 10/2016
3	VaccinesIBA 10/2017 - 01/2008
3	EpitopesIBA 07/2012 - 03/2009
3	HLA-A*02:01 antigenIBA 07/2012 - 09/2007
2	Monoclonal AntibodiesIBA 01/2022 - 01/2016
2	ruxolitinibIBA 11/2021 - 02/2015
2	Vitamin D FDA LinkGeneric 10/2020 - 04/2012
2	Lenalidomide (CC 5013)FDA Link 01/2020 - 01/2018
2	axicabtagene ciloleucelIBA 12/2019 - 12/2019
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2019 - 01/2019
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2019 - 01/2019
2	LigandsIBA 01/2016 - 06/2011
2	AntibodiesIBA 01/2016 - 03/2009
2	Imatinib Mesylate (Gleevec)FDA Link 12/2015 - 10/2005
2	Dihydrotachysterol (AT 10)IBA 11/2014 - 02/2014
2	Pancreatic Elastase (Elastase)IBA 07/2012 - 07/2007

Therapy/Procedure

101	Cell Transplantation 11/2022 - 07/2012
74	Transplantation 01/2022 - 03/2005
50	Therapeutics 01/2022 - 03/2006
44	Stem Cell Transplantation 01/2022 - 08/2005
27	Hematopoietic Stem Cell Transplantation 01/2021 - 08/2010
14	Homologous Transplantation 11/2021 - 02/2012
12	Drug Therapy (Chemotherapy) 01/2021 - 06/2011
9	Autologous Transplantation 01/2020 - 07/2013
7	Immunotherapy 01/2022 - 03/2009
5	Bone Marrow Transplantation (Transplantation, Bone Marrow) 01/2022 - 01/2016
5	Haploidentical Transplantation 10/2020 - 01/2017
4	Activities of Daily Living (ADL) 01/2019 - 01/2019
3	Photopheresis 03/2021 - 10/2009
3	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2021 - 08/2005
3	Radiotherapy 08/2017 - 07/2012
2	Blood Component Removal (Apheresis) 01/2020 - 01/2015